Clover Health (CLOV) Response to Short Seller 'Compelling' - BofA Securities
Tweet
Share
E-mailGet Alerts CLOV Hot Sheet
Price: $4.27 -7.17%
Rating Summary:
2 Buy, 4 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
2 Buy, 4 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
BofA Securities analyst Kevin Fischbeck reiterated a Buy rating and $20.00 price target on Clover Health (NASDAQ: CLOV), saying the company's response to the short seller was "compelling."
For an analyst ratings summary and ratings history on Clover Health click here. For more ratings news on Clover Health click here.
Shares of Clover Health closed at $12.64 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wolfpack Research: 'we are short FTK because their $400m deal has been canceled'
- Freedom Broker Upgrades PrimeEnergy Resource (PNRG) to Hold
- Trump on Iran: they're not going to make the kind of deal that I think is necessary
Create E-mail Alert Related Categories
Analyst Comments, Short Sales, Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
